[1]
2026. In Silico Evaluation of Bioactive Compounds from Caesalpinia sappan L. as Lipase and Penicillin-Binding Protein Inhibitors for Antibacterial Therapy. Pharmaceutical Reports. 5, 1 (Mar. 2026). DOI:https://doi.org/10.33096/pharmrep.v5i1.404.